home / stock / pxxlf / pxxlf quote
Last: | $0.70 |
---|---|
Change Percent: | 0.0% |
Open: | $0.7 |
Close: | $0.70 |
High: | $0.7 |
Low: | $0.7 |
Volume: | 100 |
Last Trade Date Time: | 04/11/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.7 | $0.7 | $0.7 | $0.7 | $0.7 | 100 | 04-11-2024 |
$0.545 | $0 | $0.545 | $0 | $0 | 2,200 | 03-11-2024 |
$0.545 | $0.545 | $0.545 | $0.545 | $0.545 | 105 | 02-06-2024 |
$0.6 | $0 | $0.6 | $0 | $0 | 24 | 10-20-2023 |
$0.6 | $0.6 | $0.6 | $0.6 | $0.6 | 579 | 08-08-2023 |
$0.83 | $0.83 | $0.83 | $0.83 | $0.83 | 370 | 05-16-2023 |
$2.6 | $2.6 | $2.6 | $2.6 | $2.6 | 1,000 | 08-16-2022 |
$2.1 | $2.1 | $2.1 | $2.1 | $2.1 | 500 | 04-28-2022 |
$2.36 | $2.36 | $2.36 | $2.36 | $2.36 | 980 | 04-21-2022 |
$5.825 | $5.825 | $5.825 | $5.825 | $5.825 | 500 | 01-03-2022 |
$5.48 | $5.48 | $5.48 | $5.48 | $5.48 | 1,200 | 12-30-2021 |
$6.7 | $6.7 | $6.7 | $6.7 | $6.7 | 101 | 08-10-2021 |
$6.47 | $6.47 | $6.47 | $6.47 | $6.47 | 140 | 08-05-2021 |
$7.0418 | $7.0418 | $7.0418 | $7.0418 | $7.0418 | 595 | 07-23-2021 |
$8.19 | $8.19 | $8.19 | $8.19 | $8.19 | 14,065 | 05-17-2021 |
$8 | $8 | $8 | $8 | $8 | 357 | 03-05-2021 |
$8.1612 | $8.1612 | $8.1612 | $8.1612 | $8.1612 | 200 | 02-18-2021 |
$8.1687 | $8.1687 | $8.1687 | $8.1687 | $8.1687 | 125 | 12-07-2020 |
$7.7 | $7.7 | $7.7 | $7.7 | $7.7 | 1,494 | 10-05-2020 |
$7.8 | $7.8 | $7.8 | $7.8 | $7.8 | 2,000 | 08-10-2020 |
News, Short Squeeze, Breakout and More Instantly...
Poxel SA Company Name:
PXXLF Stock Symbol:
OTCMKTS Market:
TWYMEEG gross sales in Japan should exceed its FY 2023 1 guidance 2 of JPY 4.2 billion (EUR 25.7 million) 3 driven by a favourable sales trend in Japan. Sumitomo Pharma to report full year results on May 14 th , 2024 Company expects TWYMEEG’s FY 2024 4 forecast ...
Exclusive discussions and finalization of related documentation underway with a leading investor to monetize royalties from TWYMEEG ® (Imeglimin) sales in Japan Cash runway estimated to be sufficient until the completion of the transaction expected by the end of April, including ...
TWYMEEG ® sales continue to perform well in Japan with JPY 3.5 billion (EUR 22.4 million 1 ) total sales over the first 3 quarters of 2023 2 , up +170% vs. the corresponding period in 2022. This growth trajectory is in line to meet or potentially surpass Sumitomo Pharma’s ...